The Patent Finder

Terms ending in 2028

AbbVie Inc.

Every in-force patent on AbbVie Inc.'s record whose computed term ends in 2028, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 7,547,678Method for Treating a Disease, Disorder or Adverse Effect Caused by an Elevated Serum Concentration of an Ugtiai Substrate
In force
 · High confidence
AbbVie Inc.In forceHigh confidence
US 7,750,004Apoptosis Promoters
In force
 · High confidence
AbbVie Inc.In forceHigh confidence
US 7,576,110Benzothiazole Cyclobutyl Amine Derivatives
In force
 · High confidence
AbbVie Inc.In forceHigh confidence
US 7,790,741Novel Imidazothiazoles and Imidazoxazoles
In force
 · High confidence
AbbVie Inc.In forceHigh confidence
US 8,183,250Potent Parp Inhibitors
In force
 · High confidence
AbbVie Inc.In forceHigh confidence
US 9,592,293INTERLEUKIN-13 Binding Proteins
In force
 · High confidence
AbbVie Inc.In forceHigh confidence
US 8,410,259Recombinant Expression Vector Elements (REVES) for Enhancing Expression of Recombinant Proteins in Host Cells
In force
 · High confidence
AbbVie Inc.In forceHigh confidence
US 9,035,0477-Substituted Indole MCL-1 Inhibitors
In force
 · High confidence
AbbVie Inc.In forceHigh confidence
US 9,359,2967-Substituted Indole MCL-1 Inhibitors
In force
 · High confidence
AbbVie Inc.In forceHigh confidence
US 8,546,368Pyrazoloquinolones Are Potent Parp Inhibitors
In force
 · High confidence
AbbVie Inc.In forceHigh confidence
20 more term ends in 2028 · Pro
10 of 30 patents shown. Soonest term end first, then patent number.
Pro members see all 30, including 9 expiring within the 18 months from Nov 21, 2026.
Upgrade to Pro
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited